Antibiotics · 2023 · 40 citations · 24 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceAntimicrobial Resistance EpidemiologyMedical MicrobiologyAntibacterial ResistanceAntibiotic ResistanceAntibiotic Resistance MechanismsAntimicrobial Resistance ControlBacterial InfectionsMultidrug ResistanceAntibiotic Susceptibility TestingAntimicrobial Resistance MonitoringAntimicrobial Resistance PatternsDrug Resistance Pattern AnalysisKlebsiella Pneumoniae ResistanceMultidrug-resistant OrganismsMultidrug-resistant PathogensResistance Pattern Monitoring
Infectious disease is one of the greatest causes of morbidity and mortality worldwide, and with the emergence of antimicrobial resistance, the situation is worsening. In order to prevent this crisis, antimicrobial resistance needs to be monitored carefully to control the spread of multidrug-resistant bacteria. Therefore, in this study, we aimed to determine the prevalence of infection caused by Klebsiella pneumoniae and investigate the antimicrobial profile pattern of K. pneumoniae in the last eleven years. This retrospective study was conducted in a tertiary hospital in Makkah, Saudi Arabia. Data were collected from January 2011 to December 2021. From 2011 to 2021, a total of 61,027 bacterial isolates were collected from clinical samples, among which 14.7% (n = 9014) were K. pneumoniae. The antibiotic susceptibility pattern of K. pneumoniae revealed a significant increase in the resistance rate in most tested antibiotics during the study period. A marked jump in the resistance rate was seen in amoxicillin/clavulanate and piperacillin/tazobactam, from 33.6% and 13.6% in 2011 to 71.4% and 84.9% in 2021, respectively. Ceftazidime, cefotaxime, and cefepime resistance rates increased from 29.9%, 26.2%, and 53.9%, respectively, in 2011 to become 84.9%, 85.1%, and 85.8% in 2021. Moreover, a significant increase in the resistance rate was seen in both imipenem and amikacin, with an average resistance rate rise from 6.6% for imipenem and 11.9% for amikacin in 2011 to 59.9% and 62.2% in 2021, respectively. The present study showed that the prevalence and drug resistance of K. pneumoniae increased over the study period. Thus, preventing hospital-acquired infection and the reasonable use of antibiotics must be implemented to control and reduce antimicrobial resistance.
24
Hera Nirwati, Kian Sinanjung, Fahrina Fahrunissa et al. · BMC Proceedings · 2019 · 260 citations · Full text
Roumayne Lopes Ferreira, Brenda C. M. da Silva, Graziela Silva Rezende et al. · Frontiers in Microbiology · 2019 · 251 citations · Full text
Dejenie Shiferaw Teklu, Abebe Aseffa Negeri, Melese Hailu Legese et al. · Antimicrobial Resistance and Infection Control · 2019 · 221 citations · Full text